Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.

MacArthur JW Jr, Purcell BP, Shudo Y, Cohen JE, Fairman A, Trubelja A, Patel J, Hsiao P, Yang E, Lloyd K, Hiesinger W, Atluri P, Burdick JA, Woo YJ.

Circulation. 2013 Sep 10;128(11 Suppl 1):S79-86. doi: 10.1161/CIRCULATIONAHA.112.000343.

2.

Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.

Hiesinger W, Frederick JR, Atluri P, McCormick RC, Marotta N, Muenzer JR, Woo YJ.

J Thorac Cardiovasc Surg. 2010 Nov;140(5):1174-80. doi: 10.1016/j.jtcvs.2010.08.012.

3.

Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.

Macarthur JW Jr, Cohen JE, McGarvey JR, Shudo Y, Patel JB, Trubelja A, Fairman AS, Edwards BB, Hung G, Hiesinger W, Goldstone AB, Atluri P, Wilensky RL, Pilla JJ, Gorman JH 3rd, Gorman RC, Woo YJ.

Circ Res. 2014 Feb 14;114(4):650-9. doi: 10.1161/CIRCRESAHA.114.302884. Epub 2013 Dec 23.

4.

Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog.

Hiesinger W, Perez-Aguilar JM, Atluri P, Marotta NA, Frederick JR, Fitzpatrick JR 3rd, McCormick RC, Muenzer JR, Yang EC, Levit RD, Yuan LJ, Macarthur JW, Saven JG, Woo YJ.

Circulation. 2011 Sep 13;124(11 Suppl):S18-26. doi: 10.1161/CIRCULATIONAHA.110.009431.

5.

Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.

Atluri P, Miller JS, Emery RJ, Hung G, Trubelja A, Cohen JE, Lloyd K, Han J, Gaffey AC, MacArthur JW, Chen CS, Woo YJ.

J Thorac Cardiovasc Surg. 2014 Sep;148(3):1090-7; discussion 1097-8. doi: 10.1016/j.jtcvs.2014.06.038. Epub 2014 Jun 28.

6.

Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis.

Frederick JR, Fitzpatrick JR 3rd, McCormick RC, Harris DA, Kim AY, Muenzer JR, Marotta N, Smith MJ, Cohen JE, Hiesinger W, Atluri P, Woo YJ.

Circulation. 2010 Sep 14;122(11 Suppl):S107-17. doi: 10.1161/CIRCULATIONAHA.109.930404.

7.

Mathematically engineered stromal cell-derived factor-1α stem cell cytokine analog enhances mechanical properties of infarcted myocardium.

MacArthur JW Jr, Trubelja A, Shudo Y, Hsiao P, Fairman AS, Yang E, Hiesinger W, Sarver JJ, Atluri P, Woo YJ.

J Thorac Cardiovasc Surg. 2013 Jan;145(1):278-84. doi: 10.1016/j.jtcvs.2012.09.080.

8.

Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.

Gaffey AC, Chen MH, Venkataraman CM, Trubelja A, Rodell CB, Dinh PV, Hung G, MacArthur JW, Soopan RV, Burdick JA, Atluri P.

J Thorac Cardiovasc Surg. 2015 Nov;150(5):1268-76. doi: 10.1016/j.jtcvs.2015.07.035. Epub 2015 Jul 17.

9.

Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.

Woo YJ, Grand TJ, Berry MF, Atluri P, Moise MA, Hsu VM, Cohen J, Fisher O, Burdick J, Taylor M, Zentko S, Liao G, Smith M, Kolakowski S, Jayasankar V, Gardner TJ, Sweeney HL.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):321-9.

10.

Rehmannia glutinosa extract activates endothelial progenitor cells in a rat model of myocardial infarction through a SDF-1 α/CXCR4 cascade.

Wang YB, Liu YF, Lu XT, Yan FF, Wang B, Bai WW, Zhao YX.

PLoS One. 2013;8(1):e54303. doi: 10.1371/journal.pone.0054303. Epub 2013 Jan 18.

11.

Migration of marrow stromal cells in response to sustained release of stromal-derived factor-1alpha from poly(lactide ethylene oxide fumarate) hydrogels.

He X, Ma J, Jabbari E.

Int J Pharm. 2010 May 10;390(2):107-16. doi: 10.1016/j.ijpharm.2009.12.063. Epub 2010 Feb 26.

12.

Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction.

Zhu H, Jiang X, Li X, Hu M, Wan W, Wen Y, He Y, Zheng X.

Heart Vessels. 2016 Jun;31(6):963-75. doi: 10.1007/s00380-015-0710-0. Epub 2015 Jul 4.

PMID:
26142379
13.

Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.

Bonaros N, Sondermeijer H, Wiedemann D, Schlechta B, Schachner T, Schuster M, Seki T, Martens TP, Itescu S, Kocher AA.

J Thorac Cardiovasc Surg. 2011 Sep;142(3):687-96, 696.e1-2. doi: 10.1016/j.jtcvs.2011.01.014. Epub 2011 Mar 8.

14.

Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction.

Li L, Zeng H, Chen JX.

Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H605-18. doi: 10.1152/ajpheart.00366.2012. Epub 2012 Jun 29.

15.

Acute myocardial rescue with endogenous endothelial progenitor cell therapy.

Atluri P, Panlilio CM, Liao GP, Hiesinger W, Harris DA, McCormick RC, Cohen JE, Jin T, Feng W, Levit RD, Dong N, Woo YJ.

Heart Lung Circ. 2010 Nov;19(11):644-54. doi: 10.1016/j.hlc.2010.06.1056. Epub 2010 Aug 16.

16.

Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.

Westenbrink BD, Oeseburg H, Kleijn L, van der Harst P, Belonje AM, Voors AA, Schoemaker RG, de Boer RA, van Veldhuisen DJ, van Gilst WH.

Cardiovasc Drugs Ther. 2008 Aug;22(4):265-74. doi: 10.1007/s10557-008-6094-y. Epub 2008 Mar 11.

PMID:
18327705
17.

A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.

Cohen JE, Purcell BP, MacArthur JW Jr, Mu A, Shudo Y, Patel JB, Brusalis CM, Trubelja A, Fairman AS, Edwards BB, Davis MS, Hung G, Hiesinger W, Atluri P, Margulies KB, Burdick JA, Woo YJ.

Circ Heart Fail. 2014 Jul;7(4):619-26. doi: 10.1161/CIRCHEARTFAILURE.113.001273. Epub 2014 Jun 5.

18.

Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size.

Henning RJ, Burgos JD, Ondrovic L, Sanberg P, Balis J, Morgan MB.

Cell Transplant. 2006;15(7):647-58.

PMID:
17176616
19.

Hyaluronic acid-based hydrogel induces neovascularization and improves cardiac function in a rat model of myocardial infarction.

Abdalla S, Makhoul G, Duong M, Chiu RC, Cecere R.

Interact Cardiovasc Thorac Surg. 2013 Nov;17(5):767-72. doi: 10.1093/icvts/ivt277. Epub 2013 Jul 12.

20.

Supplemental Content

Support Center